AI Article Synopsis
- The study looked at how well a special scan called [18F]F-DOPA PET/CT works for diagnosing and predicting outcomes in patients with medullary thyroid cancer (MTC).
- They checked results from 109 patients and found that the scan was very accurate in detecting tumors and helped understand how severe the cancer could be.
- The results indicated that patients with negative scan results tended to live longer than those with positive results, showing that this scan can be an important tool for doctors.
Article Abstract
Objective: Correct diagnosis and prognostic evaluation of medullary thyroid cancer (MTC) are crucial to treat patients. The purpose of this study was to evaluate the diagnostic and prognostic value of [18F]F-DOPA PET/CT in patients with MTC.
Methods: We reviewed MTC patients who underwent [18F]F-DOPA PET/CT from June 2008 to November 2023. Clinical characteristics, follow-up data, and the following [18F]F-DOPA PET/CT parameters were recorded: maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume (MTV), and SUVmean of multiple organs. The diagnostic value of PET/CT for the detection of tumor lesions was calculated. Serum basal calcitonin (bCt) and stimulated calcitonin (sCt) were determined. Receiver operating characteristics, Kaplan-Meier, and Cox regression analyses were performed.
Results: In total, 109 patients (50 women, 59 men; average age, 55 ± 14 years) were included in the analysis. The patient-related sensitivity, specificity, and accuracy of [18F]F-DOPA PET/CT were 95%, 93%, and 94%, respectively. The lesion-related sensitivity, specificity, and accuracy were 65%, 99%, and 72%, respectively. The optimal cutoff values of bCt, sCt, and CEA to obtain positive [18F]F-DOPA PET/CT results were 64 pg/mL, 1808 pg/mL, and 4 µg/L, respectively. Patients with negative [18F]F-DOPA PET/CT had longer overall survival than patients with positive [18F]F-DOPA PET/CT results (P = 0.017). Significant positive correlations were found between bCt, sCt, and CEA with SUVmax, SUVmean, and MTV of [18F]F-DOPA PET/CT (P < 0.001). [18F]F-DOPA PET/CT results and MTV may be useful for the evaluation of the prognosis of patients with recurrent MTC, while age and MTV were independent prognostic factors in patients with primary MTC. For all patients, SUVmean of the left kidney, liver, aorta, and pancreas might be used to independently predict OS.
Conclusion: [18F]F-DOPA PET/CT had great value for diagnosis and prognostic assessment in patients with MTC. The DOPA PET/CT parameter SUVmean and MTV showed significant association with OS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301540 | PMC |
| http://dx.doi.org/10.1530/ETJ-24-0089 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A New Tool for Extracting Static and Dynamic Parameters from [F]F-DOPA PET/CT in Pediatric Gliomas.
J Clin Med
October 2024
Department of Informatics, Bioengineering, Robotics and System Engineering (DIBRIS), University of Genoa, 16145 Genoa, Italy.
Article Synopsis
- PET imaging with [F]F-DOPA shows promise for assessing pediatric brain gliomas, but manual extraction of data is slow and inconsistent.
- A new semi-automated Python framework was developed to streamline the processing of PET images and improve efficiency and accuracy in calculating clinical scores.
- The study found that this new method significantly improved reproducibility in extracting important tumor metrics and reduced the variability associated with human input.
The role of [18F]F-DOPA PET/CT in diagnostic and prognostic assessment of medullary thyroid cancer: a 15-year experience with 109 patients.
Eur Thyroid J
August 2024
Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
Article Synopsis
- The study looked at how well a special scan called [18F]F-DOPA PET/CT works for diagnosing and predicting outcomes in patients with medullary thyroid cancer (MTC).
- They checked results from 109 patients and found that the scan was very accurate in detecting tumors and helped understand how severe the cancer could be.
- The results indicated that patients with negative scan results tended to live longer than those with positive results, showing that this scan can be an important tool for doctors.
The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.
Eur J Nucl Med Mol Imaging
February 2024
Nuclear Medicine Unit, Department of Medicine - DIMED, University Hospital of Padova, Padua, Italy.
Article Synopsis
- Scientists are studying different types of imaging to see how well they can find and assess neuroblastoma in kids, especially comparing a method called mIBG with new PET scans.!
- They looked at 10 studies involving 181 patients and found that the PET scans could detect more tumors than the mIBG method in many cases.!
- Although PET scans seem to work better, doctors are still figuring out if this will really change how they treat patients in the future.!
Towards an Automated Approach to the Semi-Quantification of [F]F-DOPA PET in Pediatric-Type Diffuse Gliomas.
J Clin Med
April 2023
Istituto Nazionale di Fisica Nucleare (INFN), 16146 Genoa, Italy.
Background: This study aims to evaluate the use of a computer-aided, semi-quantification approach to [F]F-DOPA positron emission tomography (PET) in pediatric-type diffuse gliomas (PDGs) to calculate the tumor-to-background ratio.
Methods: A total of 18 pediatric patients with PDGs underwent magnetic resonance imaging and [F]F-DOPA PET, which were analyzed using both manual and automated procedures. The former provided a tumor-to-normal-tissue ratio () and tumor-to-striatal-tissue ratio (), while the latter provided analogous scores (, ).
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms.
Curr Treat Options Oncol
May 2022
Nuclear Medicine, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Neuroendocrine neoplasms (NEN) are a heterogeneous group of tumours derived from cells of neuroendocrine origin and can potentially arise everywhere in the human body. The diagnostic assessment of NEN can be performed using a variety of PET radiopharmaceuticals. Well-differentiated NEN (NET) present a high expression of SSTR (somatostatin receptors) and can therefore be studied with 68Ga-DOTA-peptides ([68Ga]Ga-DOTANOC, [68Ga]Ga-DOTATOC, [68Ga]Ga-DOTATATE).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!